• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. ACHIEVE ADVANCE MAPPING CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. ACHIEVE ADVANCE MAPPING CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECT Back to Search Results
Model Number 2ACH20
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Bacterial Infection (1735); Stroke/CVA (1770); Erythema (1840); Fistula (1862); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914); Myocardial Infarction (1969); Dizziness (2194); Cardiac Tamponade (2226); Syncope/Fainting (4411)
Event Date 01/01/2023
Event Type  Injury  
Manufacturer Narrative
This information is based entirely on journal literature.Medtronic was made aware of this event through a search of literature publications.This event occurred outside the us.Patient information is limited due to confidentiality concerns.Of note, multiple patients and multiple manufacturers were noted in the article; however, a one-to-one correlation could not be made with unique product serial/lot numbers.The baseline gender/age characteristics is male/64 years old.Without a lot number or device serial number, the manufacturing date cannot be determined.Since no device id was provided, it is unknown if this event has been previously reported.Referenced article: efficacy and safety of proglide use and early discharge after atrial fibrillation ablation compared to standard approach.Profa trial.Pacing and clinical electrophysiology.2023; 46:598¿606.Doi: 10.1111/pace.14753 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Literature was reviewed regarding cryoballoon ablation.Patients were divided into two groups, those with a strategy of vascular suture mediated closure system utilization and early discharge or traditional closure and overnight hospitalization.The authors described patients who experienced complications in both groups.There were six patients that had an emergency visit or were admitted in the first 30 days after procedure.One patient had a medically treated stroke with no permanent injury after discharge, there was a patient with erythema related to direct current cardioversion during atrial fibrillation ablation procedure associated with nonspecific dizziness.Another patient had thoracic pain, bleeding related to femoral access, hypotension, and troponin rise.A coronary angiography was performed with no coronary artery stenosis and a type ii myocardial infarction was diagnosed.One patient experienced access site pain and an arteriovenous fistula was diagnosed and treated with a stent.There was one with symptomatic atrial fibrillation recurrence and another patient had and emergency visit because of pulmonary infection.There were other patients that experienced syncope, bleeding in the access site, arrhythmic problems (nodal rhythm after electrical cardioversion, sinus pauses after electrical cardioversion and monomorphic ventricular tachycardia after electrical cardioversion), hypotension, suspected pericardial tamponade that was not confirmed by echocardiography, and temporary phrenic paralysis.The status of the catheters and sheaths is unknown.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACHIEVE ADVANCE MAPPING CATHETER
Type of Device
CATHETER, ELECTRODE RECORDING, OR PROBE, ELECT
Manufacturer (Section D)
MEDTRONIC, INC.
8200 coral sea street ne
mounds view MN 55112
Manufacturer (Section G)
MEDTRONIC, INC.
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19053246
MDR Text Key339551189
Report Number2182208-2024-01493
Device Sequence Number1
Product Code DRF
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K162892
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 04/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number2ACH20
Device Catalogue Number2ACH20
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/27/2024
Initial Date FDA Received04/05/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Life Threatening;
Patient Age64 YR
Patient SexMale
Patient Weight84 KG
-
-